Pharmaceutical MedTech Analysis l Report Store l Pharma Intelligence

Asia-Pacific Disease Incidence and Prevalence

The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam.

January 1, 2016

Find out more

U.S. Patient Monitoring Devices Market, November 2015

$5,250.00

This report provides a summary of the nearly $2 billion U.S. patient monitoring devices market.

November 2, 2015

Find out more

Q2 2017 Meddevicetracker Outlook Report

$4,750.00

Our Early 2017 Outlook Report highlighted several high-impact catalysts. In this report, we cover catalysts from 14 devices expected to occur in Q2 2017.

March 31, 2017

Find out more

Angioplasty Catheters Market

$4,750.00

This comprehensive medical market and technology report provides an overview and in-depth market analysis of angioplasty catheters, specifically plain old balloon angioplasty (POBA), drug-coated balloon (DCB), cutting balloon, and scoring balloon catheters, used in the treatment of severe coronary artery disease (CAD) and peripheral artery disease (PAD).

November 28, 2017

Find out more

Inhalation Drug Delivery Devices Market

$4,750.00

The combined prevalence of asthma and COPD in the countries covered by this report (US, Japan, and five major EU markets of France, Germany, Italy, Spain, and the UK) is 109.3 million. The combined market for inhalation drug delivery devices totaled nearly $11.7bn in 2016, and is expected to climb at a rate of 1.2% over the forecast period. Generic erosion will be a key factor in limiting growth in the overall market; however, increasing disease prevalence and the introduction of novel products such as triple combination therapies will offset declines. The US accounts for nearly two-thirds of the overall inhalation drug delivery devices market, and is expected to experience the most growth over the forecast period as its population increases and ages.

July 19, 2017

Find out more

U.S. Markets for Anesthesia and Ventilation Products, February 2015

$4,750.00

A major driver of the U.S. anesthesia delivery systems market is the increase in surgical procedure volumes; this is largely due to the aging of the population, and will continue over the forecast period covered by this report.

February 1, 2015

Find out more

Wound Care: Tissue-Engineered Skin Replacements and Active Wound Repair Modulators

$4,750.00

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the US, 5EU, Japan, and RoW markets for tissue-engineered skin replacements (epidermal, dermal, and multilayer equivalents, and amniotic tissue grafts) and active wound repair modulators (growth factors, gene therapy agents, and stem cells).

September 23, 2020

Find out more

International Markets for Vascular Access Site Closure Devices

$4,750.00

Cardiovascular diseases (CVDs) are the leading causes of death throughout the world. Based on Datamonitor Healthcare estimates, approximately 500 million CVD-related cases occurred in the United States (U.S.), China, Japan, and the five major countries of Europe (France, Germany, Italy, Spain, and the United Kingdom [U.K.]).

June 30, 2016

Find out more

Global Markets for Orthobiologics for the Repair and Regeneration of Bone

$4,750.00

The management of musculoskeletal (MSK) disorders is dependent on several factors: geographic location location in the body, cause, patient history, and severity. Treatment options include lifestyle changes, pharmaceutical therapies, and interventional (ie device-based) therapies.

September 30, 2016

Find out more

Triple-Negative Breast Cancer KOL Interview – UK

$599.00

A UK-based key opinion leader providers insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for triple- negative breast cancer. Diagnostic testing, biomarker disease segmentation, and unmet needs are also discussed. Key pipeline assets highlighted include balixafortide, Keytruda, sacituzumab govitecan, trastuzumab deruxtecan, and veliparib.

October 31, 2019

Find out more

Interventional Cardiology: Atherectomy and Thromboembolectomy

$4,750.00

The global market for atherectomy and thromboembolectomy products is anticipated to see moderate, single-digit growth throughout the forecast period covered by this analysis (2016-22). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually.

April 5, 2018

Find out more

Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

$4,750.00

This report provides an overview of primary neurological diseases/disorders treated with deep brain stimulation (DBS) and vagus nerve stimulation (VNS), as well as overviews of DBS and VNS neuromodulation technologies, competitors, sales, forecasts, and competitive and market analysis. Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.

May 26, 2022

Find out more

Global Markets for Infection Control and Biosafety Products, October 2016

$4,750.00

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global medical waste disposal, device reprocessing, standard and safety needle/syringe, sharps disposal, and sterilization equipment and services markets.

October 7, 2016

Find out more

U.S. Markets for Diagnostic Oncology-Related X-Ray-Based Imaging Products

$3,750.00

Discoveries in molecular medicine in recent years have allowed researchers to study the genetic/chromosomal alterations that trigger the transformation of normal cells into malignant cells, which ultimately has led to the understanding that cancer—of which there are more than 100 forms—is a disease of the cellular genome.

March 1, 2013

Find out more

Blood Gas Monitoring Systems

$4,750.00

Arterial blood gases are the most commonly ordered test in critical care settings such as ICUs and ORs.Tests with rapid turnaround times, such as POC tests, are largely replacing the slower laboratory test market.

March 28, 2019

Find out more

Biomedtracker Early 2021 Outlook Report

$4,750.00

In this report, we cover catalysts from 28 drugs, devices, diagnostics, and deals expected to occur in early 2021. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

February 1, 2021

Find out more

European Surgical Procedure Volumes: Breast, general, gynecologic, organ transplant, neurosurgical, ophthalmalogic, and urologic

$3,000.00

This report presents procedure volumes forecasts for some of the most common surgical procedures performed in the five EU countries of France, Germany, Italy, Spain, and the UK (5EU).

December 12, 2017

Find out more

Neuromodulation: Spinal Cord Stimulation Devices Market

$4,750.00

According to a recent CDC study, 20.1% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities with similar numbers being reported in Europe. In 2021, the spinal cord stimulation (SCS) devices market was worth nearly $2.9 bn. Market drivers of the SCS devices market through 2026 will be driven by an aging population and an increase in selected conditions (eg back/leg pain, and a growing number of indications) that result in debilitating and unrelenting chronic pain.

February 22, 2022

Find out more

Pulse Oximetry Devices Market

$3,000.00

This report provides an overview of pulse oximetry, and profiles selected leading products and technologies. The report also provides a market and competitive analysis of the global pulse oximetry devices market, including five-year market forecast and share by supplier.

December 22, 2017

Find out more

U.S. Markets for Orthopedic Biomaterials for Viscosupplementation and Cartilage, Ligament/Tendon, and Meniscal Repair and Regeneration

$3,750.00

The United States (U.S.) market for orthopedic biomaterials, as covered by the scope of this report, comprises bioresorbable fixation devices, visco supplementation products, cartilage repair and regeneration technologies.

July 1, 2013

Find out more

Type 1 Diabetes KOL Interview – US, Midwest

$599.00

This interview with a US Key Opinion Leader (KOL) provides insight into current therapies for type 1 diabetes, as well as pricing pressures within the diabetes market.

January 8, 2020

Find out more

Arthroscopy Products and Sports Medicine Fixation Implants (2021)

$4,750.00

This Meddevicetracker report provides an analysis of the market for arthroscopy products (including visualization systems, fluid management equipment, and manual and powered instruments) and sports medicine/soft tissue fixation implants for the US, five major EU markets, Japan, and the rest of the world.

March 18, 2021

Find out more

Global Spinal Implants Market

$5,250.00

Spine disorders are a leading driver of healthcare costs worldwide, and range in severity from mild pain and loss of feeling to extreme pain and paralysis. These disorders are primarily caused by degenerative conditions in the spine, deformity, tumors and trauma.

December 1, 2015

Find out more

The Real Value of Medtech Markets: The impact of currency movements

$2,995.00

This report provides a comprehensive picture of the global medical orthopaedics market and relevant background, using the latest data and expert analysis. The report covers the top 160 markets by estimated US dollar value in 2019.

November 27, 2019

Find out more

Spain, Neurological Market Opportunities: Disease Incidence and Prevalence, And Surgical Procedure Volumes

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Spain

December 3, 2012

Find out more

2017 Biomedtracker / Meddevicetracker / Datamonitor Healthcare Post-ACC Report

$599.00

The American College of Cardiology (ACC) 66th Scientific Session was held in Washington, DC from 17–19 March 2017.

April 26, 2017

Find out more

Germany, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and interventional procedures in Germany; incidence and prevalence figures are compared with those of the Benelux countries

November 1, 2012

Find out more

Drug Delivery: Injection Devices

$4,750.00

Despite its relative invasiveness and technological maturity, instrument-based injection of pharmaceutical preparations is regarded as one of the most accurate, effective, reliable, and reproducible methods of therapeutic drug and fluid delivery.

December 17, 2019

Find out more

U.S. Markets for Respiratory Care Products

$4,750.00

The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lost worker productivity. The combined U.S. market for respiratory products totalled more than $4.9 billion in 2015, and is expected to climb at a rate of 7% over the forecast period.

June 20, 2016

Find out more

Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

$4,750.00

Valued at approximately $1.1bn in 2017, the implantable Deep Brain Stimulation (DBS) and Vagus Nerve Stimulation (VNS) Device Markets are two important and growing neuromodulation segments (outside of the largest, most dynamic $2.5bn segment, Spinal Cord Stimulation or SCS).

August 31, 2018

Find out more

MedTech analysis

Asia-Pacific Disease Incidence and Prevalence

U.S. Patient Monitoring Devices Market, November 2015

Q2 2017 Meddevicetracker Outlook Report

Angioplasty Catheters Market

Inhalation Drug Delivery Devices Market

U.S. Markets for Anesthesia and Ventilation Products, February 2015

Wound Care: Tissue-Engineered Skin Replacements and Active Wound Repair Modulators

International Markets for Vascular Access Site Closure Devices

Global Markets for Orthobiologics for the Repair and Regeneration of Bone

Triple-Negative Breast Cancer KOL Interview – UK

Interventional Cardiology: Atherectomy and Thromboembolectomy

Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

Global Markets for Infection Control and Biosafety Products, October 2016

U.S. Markets for Diagnostic Oncology-Related X-Ray-Based Imaging Products

Blood Gas Monitoring Systems

Biomedtracker Early 2021 Outlook Report

European Surgical Procedure Volumes: Breast, general, gynecologic, organ transplant, neurosurgical, ophthalmalogic, and urologic

Neuromodulation: Spinal Cord Stimulation Devices Market

Pulse Oximetry Devices Market

U.S. Markets for Orthopedic Biomaterials for Viscosupplementation and Cartilage, Ligament/Tendon, and Meniscal Repair and Regeneration

Type 1 Diabetes KOL Interview – US, Midwest

Arthroscopy Products and Sports Medicine Fixation Implants (2021)

Global Spinal Implants Market

The Real Value of Medtech Markets: The impact of currency movements

Spain, Neurological Market Opportunities: Disease Incidence and Prevalence, And Surgical Procedure Volumes

2017 Biomedtracker / Meddevicetracker / Datamonitor Healthcare Post-ACC Report

Germany, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

Drug Delivery: Injection Devices

U.S. Markets for Respiratory Care Products

Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market